elexxion AG (XETRA: E8X.DE) Stock Competitors & Peer Comparison
See E8X.DE's competitors and their performance on the XETRA and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for E8X.DE and its XETRA peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| E8X.DE | €0.14 | +1.45% | 1.5M | -1.08 | -€0.13 | N/A |
| ABL.DE | €99.36 | +0.93% | 171.9B | 25.96 | €3.83 | +2.12% |
| SYK.DE | €282.25 | +0.61% | 108.2B | 30.03 | €9.40 | +1.06% |
| 2M6.DE | €79.66 | -0.75% | 102B | 16.77 | €4.75 | +3.06% |
| SHL.DE | €40.20 | +0.98% | 45B | 17.12 | €2.35 | +2.49% |
| PHI1.DE | €23.61 | -0.46% | 23.1B | 18.56 | €1.27 | +3.60% |
| DRW3.DE | €110.80 | +0.36% | 2.1B | 12.16 | €9.11 | +2.05% |
| DRW8.DE | €82.20 | +0.74% | 2B | 9.04 | €9.09 | +2.05% |
| SBS.DE | €21.65 | +0.23% | 263.2M | 30.69 | €0.71 | +2.77% |
| GME.DE | €2.59 | -2.26% | 14M | 4.11 | €0.63 | +3.86% |
Stock Comparison
Abbott Laboratories (XETRA: ABL.DE)
E8X.DE vs ABL.DE Comparison August 2026
elexxion AG (XETRA: E8X.DE) plays a significant role within the Healthcare sector. Its performance on the XETRA reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, E8X.DE stands at 1.5M. In comparison, ABL.DE has a market cap of 171.9B. Regarding current trading prices, E8X.DE is priced at €0.14 on the XETRA, while ABL.DE trades at €99.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
E8X.DE currently has a P/E ratio of -1.08, whereas ABL.DE's P/E ratio is 25.96. In terms of profitability, E8X.DE's ROE is +0.29%, compared to ABL.DE's ROE of +0.11%. Regarding short-term risk, E8X.DE is more volatile compared to ABL.DE. This indicates higher risk in terms of short-term price fluctuations for E8X.DE.Check ABL.DE's competition here